NSE ScannerChemicals · Chemicals: Specialty · NSE: INDIAGLYCO · data 2026-10-31
India Glycols Limited
In plain words
Price: 16.9% below its 52-week high of ₹399.
Delivery: 25.9% of traded shares were kept for delivery over the last 10 sessions, against 39.6% over the last 60.
Latest results: a net profit of ₹97 cr for the quarter ended Jun 2026 (+32.2% on the same quarter a year earlier).
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹4,301 cr |
| Net profit (last 12 months) | ₹316 cr |
| Sales growth, 3 years (yearly) | 16.8% |
| Profit growth, 3 years (yearly) | 32.8% |
At a glance
Promoters 59.6% (-1.4 pts in a year), pledged 0.0%, institutions 5.8%.
P/E 6.8, dividend yield 3.8%. Price relative to earnings and book value (low is cheaper, not better).
ROE 11.3%, ROCE 12.0%, operating margin 11.8%: how much profit it earns on the money it uses.
Debt/equity 0.58, Profit growth 32.8% and sales growth 16.8% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- Profit grew 32.8% a year over 3 years.
- Pays a dividend yielding 3.8%.
- Promoters cut their holding by 1.4 points in a year.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Latest results in brief (Q1 FY27)
INDIAGLYCO Q1 FY27 results (consolidated figures, as filed on NSE).
Revenue was ₹2,988.44 crore, up 19.4% YoY and up 26.6% QoQ.
Net profit was ₹96.83 crore, up 32.2% YoY and up 11.5% QoQ.
Operating margin was 5.7% (6% a year ago).
EPS was ₹14.45, up 32.2% YoY and up 5.9% QoQ.
INDIAGLYCO के Q1 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।
राजस्व: ₹2,988.44 करोड़; पिछले साल की तुलना में 19.4% की बढ़त, पिछली तिमाही की तुलना में 26.6% की बढ़त।
शुद्ध मुनाफ़ा: ₹96.83 करोड़; पिछले साल की तुलना में 32.2% की बढ़त, पिछली तिमाही की तुलना में 11.5% की बढ़त।
ऑपरेटिंग मार्जिन: 5.7% (एक साल पहले 6%)।
EPS: ₹14.45; पिछले साल की तुलना में 32.2% की बढ़त, पिछली तिमाही की तुलना में 5.9% की बढ़त।
INDIAGLYCOના Q1 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹2,988.44 કરોડ; ગયા વર્ષની સરખામણીએ 19.4% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 26.6% વધારો.
ચોખ્ખો નફો: ₹96.83 કરોડ; ગયા વર્ષની સરખામણીએ 32.2% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 11.5% વધારો.
ઓપરેટિંગ માર્જિન: 5.7% (એક વર્ષ પહેલાં 6%).
EPS: ₹14.45; ગયા વર્ષની સરખામણીએ 32.2% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 5.9% વધારો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
12/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 0/30: Delivery 12.6% over the last 20 sessions vs 37.9% in the 40 before (0.33x); shares delivered per day 0.49x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 7/20: Net +₹4.09 cr bought in bulk/block deals over 90 days (0.05x a usual day's traded value); 1 net buying day, 0 net selling days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Deal ● Results ● Dividend ● Split
- 13 Oct 26Deal Bulk deal: IRAGE BROKING SERVICES LLP bought ₹4.09 cr +9.4% next session
- 12 Aug 26Results Q1 FY27 results: profit +32.2% YoY -1.6% next session
- 14 May 26Results Q4 FY26 results: profit +35.7% YoY -7.1% next session
- 23 Mar 26Dividend Dividend ₹7.5 (ex-date) -3.2% next session
- 10 Feb 26Results Q3 FY26 results: profit +18.9% YoY +0.3% next session
- 14 Nov 25Results Q2 FY26 results: profit +30.9% YoY +5.4% next session
- 23 Sept 25Dividend Dividend ₹5 (ex-date) -0.1% next session
- 12 Aug 25Split Split: face value ₹10 → ₹5 (ex-date) -7.1% next session
- 7 Aug 25Results Q1 FY26 results: profit +21.3% YoY -2.1% next session
- 16 May 25Results Q4 FY25 results: profit +51.7% YoY -2.3% next session
- 5 Feb 25Results Q3 FY25 results: profit +36.5% YoY -3.1% next session
- 9 Dec 24Results Q2 FY25 results: profit +30.8% YoY +4.0% next session
- 7 Nov 24Results Results board meeting -4.2% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Jun 2026 | ₹2,988 cr | ₹97 cr | +32.2% | 5.7% | 14.45 |
| Mar 2026 | ₹2,360 cr | ₹87 cr | +35.7% | 7.1% | 13.64 |
| Dec 2025 | ₹2,551 cr | ₹68 cr | +18.9% | 6.9% | 10.79 |
| Sept 2025 | ₹2,412 cr | ₹65 cr | +30.9% | 6.5% | 10.51 |
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 59.63% | 59.63% | 59.63% | 59.63% |
| Foreign institutions (FII) | 2.76% | 2.24% | 2.27% | 2.42% |
| Domestic institutions (DII) | 3.05% | 5.22% | 5.20% | 5.23% |
| Mutual funds | 0.10% | 0.22% | 0.20% | 0.27% |
| Retail investors | 20.37% | 18.80% | 19.39% | 19.03% |
| Number of shareholders | 60,112 | 52,968 | 52,848 | 54,301 |
Common questions
What was India Glycols Limited's latest quarterly profit?
India Glycols Limited reported a net profit of ₹97 cr for the quarter ended Jun 2026 (+32.2% on the same quarter a year earlier), on revenue of ₹2,988 cr.
How much do promoters hold in India Glycols Limited?
Promoters held 59.63% of India Glycols Limited at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is India Glycols Limited debt-free?
Its latest reported debt-to-equity ratio is 0.58.
What is India Glycols Limited's P/E ratio?
About 6.8, based on the last 12 months' earnings and a price of ₹331.7 (data 2026-10-31).
What is the 52-week high and low of India Glycols Limited?
The 52-week high is ₹399 and the 52-week low is ₹163.68.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| India Glycols Limited | ₹331.7 | ₹2,219 cr | 6.8 | — | 11.3% | 12% | 0.58 | +64.5% |
| Apcotex Industries Ltd | ₹476.75 | ₹2,485 cr | 15.3 | — | 17.3% | 18.3% | 0.16 | +34.2% |
| NOCIL Limited | ₹137.12 | ₹2,292 cr | 34.7 | — | 3.1% | 1.6% | 0 | -26.2% |
| Rossari Biotech Ltd | ₹399.25 | ₹2,212 cr | 14.5 | 1.6 | 11.8% | 13.6% | 0.33 | -38.2% |
| JG Chemicals Limited | ₹562.4 | ₹2,205 cr | 29.3 | — | 13.3% | 14% | 0.01 | +28.2% |
| Shree Pushkar Chemicals & Fertilisers Ltd. | ₹602.6 | ₹1,942 cr | 27.4 | — | 12.2% | 12.9% | 0.22 | +41.3% |
Compare INDIAGLYCO with APCOTEXIND in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open INDIAGLYCO in NSE Scanner →